Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Carlyle (CGABL) EBIT (2016 - 2025)

Historic EBIT for Carlyle (CGABL) over the last 15 years, with Q3 2025 value amounting to $115.6 million.

  • Carlyle's EBIT fell 8588.69% to $115.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 16348.08%. This contributed to the annual value of $2.5 billion for FY2024, which is 198.95% up from last year.
  • Per Carlyle's latest filing, its EBIT stood at $115.6 million for Q3 2025, which was down 8588.69% from $468.6 million recorded in Q2 2025.
  • Carlyle's 5-year EBIT high stood at $1.3 billion for Q2 2021, and its period low was -$810.7 million during Q4 2023.
  • Moreover, its 5-year median value for EBIT was $294.9 million (2024), whereas its average is $402.3 million.
  • As far as peak fluctuations go, Carlyle's EBIT tumbled by 50555.28% in 2023, and later surged by 73409.67% in 2024.
  • Over the past 5 years, Carlyle's EBIT (Quarter) stood at $946.1 million in 2021, then plummeted by 78.87% to $199.9 million in 2022, then plummeted by 505.55% to -$810.7 million in 2023, then soared by 136.38% to $294.9 million in 2024, then tumbled by 60.8% to $115.6 million in 2025.
  • Its EBIT was $115.6 million in Q3 2025, compared to $468.6 million in Q2 2025 and $198.8 million in Q1 2025.